JPMorgan Chase & Co. reduced its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 15.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,693,196 shares of the real estate investment trust's stock after selling 302,629 shares during the period. JPMorgan Chase & Co. owned approximately 0.63% of Omega Healthcare Investors worth $64,087,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the company. Stonebridge Financial Group LLC acquired a new position in shares of Omega Healthcare Investors during the fourth quarter valued at approximately $26,000. Grove Bank & Trust acquired a new stake in shares of Omega Healthcare Investors during the fourth quarter valued at about $30,000. Dunhill Financial LLC purchased a new stake in Omega Healthcare Investors in the third quarter valued at approximately $31,000. Kentucky Trust Co purchased a new stake in shares of Omega Healthcare Investors in the 4th quarter valued at $38,000. Finally, UMB Bank n.a. lifted its position in shares of Omega Healthcare Investors by 68.6% during the fourth quarter. UMB Bank n.a. now owns 1,116 shares of the real estate investment trust's stock worth $42,000 after purchasing an additional 454 shares in the last quarter. 65.25% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
OHI has been the topic of a number of recent analyst reports. JMP Securities reissued a "market perform" rating on shares of Omega Healthcare Investors in a research report on Friday, February 7th. Truist Financial increased their price target on shares of Omega Healthcare Investors from $38.00 to $39.00 and gave the stock a "hold" rating in a research note on Tuesday, March 18th. Finally, Wells Fargo & Company lowered Omega Healthcare Investors from an "overweight" rating to an "equal weight" rating and dropped their target price for the company from $41.00 to $39.00 in a report on Thursday, March 27th. Six equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $42.00.
Get Our Latest Stock Analysis on Omega Healthcare Investors
Omega Healthcare Investors Price Performance
Omega Healthcare Investors stock traded up $1.36 during mid-day trading on Wednesday, hitting $37.57. The company's stock had a trading volume of 4,677,632 shares, compared to its average volume of 1,820,037. Omega Healthcare Investors, Inc. has a twelve month low of $29.66 and a twelve month high of $44.42. The stock has a market capitalization of $10.59 billion, a P/E ratio of 24.24, a P/E/G ratio of 1.09 and a beta of 0.75. The company has a quick ratio of 7.07, a current ratio of 7.07 and a debt-to-equity ratio of 1.02. The stock's fifty day moving average price is $37.15 and its two-hundred day moving average price is $38.59.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last issued its earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.41 by $0.33. Omega Healthcare Investors had a net margin of 38.65% and a return on equity of 9.71%. Research analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.
Omega Healthcare Investors Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th were paid a $0.67 dividend. The ex-dividend date of this dividend was Monday, February 10th. This represents a $2.68 annualized dividend and a dividend yield of 7.13%. Omega Healthcare Investors's dividend payout ratio is currently 172.90%.
Omega Healthcare Investors Company Profile
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Featured Stories

Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.